The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The approval marks a major advance in targeted treatment for this rare, chronic autoimmune disease, offering twice-yearly maintenance dosing after two initial loading doses
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
